Since it has been shown that, under experimental pathological conditions such as obesity, the liver, particularly the hepatocytes, contributes more than other organs to increasing the plasma levels of GDF15 [12], we further evaluated whether the changes in GDF15 plasma levels reflected its altered expression at the hepatic level in our patients. The gene discussed is GDF15; the disease is obesity disorder.